Showing results (1561-1570 of 1,930) with videos related to
Sort By:
Pageof 193
Infection and Immunity|October 13, 2001
Analysis of cytokines in the early development of gastric secondary lymphoid follicles in Helicobacter pylori-infected BALB/c mice with neonatal thymectomyK Uchida, K Okazaki, A Debrecceni, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1996
[Comparison of clinical effects between granisetron alone and combination of granisetron and methylprednisolone against the nausea and vomiting induced by CDDP chemotherapy--comparative study by the cross-over trial. University of Tsukuba Antiemetics Study Group]K Uchida, H Akaza, T Shimazui, et al.Veterinary Journal (London, England : 1997)|December 16, 2020
Evaluation of epithelial and mesenchymal cell markers in canine urinary bladder transitional cell carcinomaM Shinada, K Saeki, R Yoshitake, et al.Gut|July 17, 2003
Inhibitory effects of Helicobacter pylori infection on murine autoimmune gastritisM Ohana, K Okazaki, C Oshima, et al.Clinical Nephrology|July 31, 2009
Successful therapeutic use of a single-dose of rituximab on relapse in adults with minimal change nephrotic syndromeY Sawara, M Itabashi, C Kojima, et al.Diabetologia|October 16, 2012
Impact of eating rate on obesity and cardiovascular risk factors according to glucose tolerance status: the Fukuoka Diabetes Registry and the Hisayama StudyT Ohkuma, H Fujii, M Iwase, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 4, 2001
[Breast cancer]T Kobayashi, H Yamazaki, T Nakamura, et al.Physical Review Letters|August 29, 2014
Spin Hall magnetoresistance induced by a nonequilibrium proximity effectH Nakayama, M Althammer, Y-T Chen, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1982
[Clinical management of acute lymphocytic leukemia in adults. 1. Treatment of acute lymphocytic leukemia with VP (vincristine, prednisolone)--DVMP (daunorubicin, vincristine 6-mercaptopurine, prednisolone) regimen]I Takahashi, K Uchida, E Ohmoto, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1982
[Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia]I Takahashi, M Hara, E Ohmoto, et al.Pageof 193